Individuals Discontinuing Anti-Obesity Medications Put On Weight Far More Rapidly Than People Using Diet and Exercise

New research reveals that people who come off new weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds at a significantly accelerated pace than those who stop conventional lifestyle programs.

Findings released in a leading medical journal points out that while obese individuals frequently drop about a fifth of their body weight while on the medication, the weight returns at an estimated rate of nearly a kilo each month after stopping.

"Individuals buying such drugs need to be aware of the risk of quick rebound weight gain when the medication concludes," stated lead investigator Dr. Susan Jebb.

This pace of recovery implies a reversion to original weight within about one and a half years.

Comparing Approaches

The analysis, which looked at 37 of trials involving thousands of participants, contrasted the results of these new drugs with conventional dieting.

Scientists emphasize that people who lose weight through dieting typically experience a less rapid creep back—perhaps 100 grams monthly—post-intervention.

Explaining the Fast Regain

Nutrition scientists believe the mode of action of the drugs explains the accelerated rebound.

These medications copy a body's own chemical called GLP-1, which helps regulate feelings of fullness.

"Sustained high doses of GLP-1 levels several times higher than the body's typical production might result in the body to generate a reduced amount of its endogenous hormone, and could reduce responsiveness to its actions," explained Dr. Adam Collins, a dietetics expert.

"Discontinuation of this medication leads to hunger is no longer kept in check, making excessive eating a significant risk."

A Chronic Disease?

Health authorities suggest the injections for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

A number of clinicians say that, due to the significant potential of relapse, the therapy might need to be ongoing.

This perspective is echoed by pharmaceutical companies, who say that the results "underscore the chronic nature of obesity," similar to managing conditions like hypertension.

Patient Experiences

People who have discontinued the medication explain a intense resurgence of hunger.

"It felt as if a switch activating and you become starving," described an individual.

This difficulty is exacerbated if individuals have not established lasting dietary or behavioural changes during therapy.

Widespread Use

Survey data show that a significant number of adults in the UK have used these injections in the last 12 months, with demand continuing to grow.

• Use is more common among women than males.
• The middle-aged age group shows the greatest usage rates.
• Many access the drugs through private prescriptions rather than the NHS.

In conclusion, clinicians stress that while these medications are powerful agents for weight loss, they are not a permanent cure and maintained weight loss relies on integrated lifestyle management.